Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2004
05/12/2004CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas
05/11/2004US6734307 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring
05/11/2004US6734304 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
05/11/2004US6734302 Cis-imidazolines
05/11/2004US6734200 Antibiotic compounds containing a substituted oxazolidinone ring; activity against gram-positive pathogens
05/11/2004US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
05/11/2004US6734191 Chemokine receptor binding heterocyclic compounds
05/11/2004US6734143 2-methoxyimino-2(pyridinyloxymethyl)phenyl acetamides useful as fungicides
05/11/2004US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity
05/11/2004CA2136999C Peripheral vasodilating agent containing piperidine derivative as active ingredient
05/06/2004WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same
05/06/2004WO2004037820A1 Oxindole substituted piperazine derivatives
05/06/2004WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
05/06/2004WO2004037809A1 Triazole compounds for the treatment of dysmenorrhoea
05/06/2004WO2004037807A2 Medicinal arylethanolamine compounds
05/06/2004WO2004037784A2 Pyrrolidones with anti-hiv activity
05/06/2004WO2004037257A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
05/06/2004WO2004037211A2 Taxane metabolites
05/06/2004WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors
05/06/2004WO2004037166A2 Therapeutic guanidines
05/06/2004WO2004018463A3 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
05/06/2004WO2004018457A8 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
05/06/2004WO2004018449A8 Piperidine-derivatives as pde4 inhibitors
05/06/2004WO2004018044A3 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent
05/06/2004WO2004013131A3 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
05/06/2004WO2004011460A3 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
05/06/2004WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides
05/06/2004WO2003082853A8 New compounds
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004WO2002102800A9 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
05/06/2004WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists
05/06/2004WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087649 Cytotoxic agents comprising taxanes and their therapeutic use
05/06/2004US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
05/06/2004US20040087636 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
05/06/2004US20040087633 Methylidene oxazolidinone compound and preparation method thereof
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
05/06/2004US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
05/06/2004US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases
05/06/2004US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands
05/06/2004US20040087588 Parp inhibitors
05/06/2004US20040087585 Peptide deformylase inhibitors
05/06/2004US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
05/06/2004US20040087575 Therapeutic chromone compounds
05/06/2004US20040087573 Phenylpiperidines and phenylpyrrolidines
05/06/2004US20040087568 Substituted anthranilic amide derivatives and methods of use
05/06/2004US20040087548 Anticancer agents and treating immune disorders
05/06/2004US20040087434 Trivalent; oxidation resistance; high activity; forming low and high molecular weight polymers based on ligand structure
05/06/2004US20040086746 Organic light emitting diode and organic luminescent materials thereof
05/06/2004EP1415987A1 Nitrogenous aromatic ring compounds
05/06/2004EP1414818A1 Azole derivatives useful as insecticide
05/06/2004EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides
05/06/2004EP1414813A1 1,2,4-trioxolane antimalarials
05/06/2004EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/06/2004EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology
05/06/2004EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
05/06/2004EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
05/06/2004EP1414456A1 Phenyl derivatives as factor xa inhibitors
05/06/2004EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
05/06/2004EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide
05/06/2004EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/06/2004EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
05/06/2004EP1257548B1 Benzofuran carboxamides and their therapeutic use
05/06/2004EP1163237B1 Amide derivatives
05/06/2004EP1147105B1 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatement of vascular diseases
05/06/2004EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use
05/06/2004EP1036072B1 Thrombin receptor antagonists
05/06/2004CA2504272A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
05/06/2004CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
05/06/2004CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea
05/06/2004CA2498215A1 Oxindole substituted piperazine derivatives
05/05/2004CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
05/05/2004CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof
05/05/2004CN1494530A Heterocyclic diamide invertebrate pest control agents
05/05/2004CN1148361C Oxyiminoalkanoic acid derivatives
05/04/2004US6730792 β3 adrenergic agonists
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730689 Heterocyclic amides such as n-(4-(2-(((methyl)amino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders
05/04/2004US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior.
05/04/2004US6730671 Compounds useful as reversible inhibitors of cathespin S
04/2004
04/29/2004WO2004035573A1 Method for preparing risperidone
04/29/2004WO2004035572A1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n’-(5-methyl-3-isoxazolyl)urea salt in crystalline form
04/29/2004WO2004035569A2 Novel compounds with antibacterial activity
04/29/2004WO2004035548A1 Novel compounds
04/29/2004WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/29/2004WO2004035538A1 Process for making azetidine-3-carboxylic acid
04/29/2004WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/29/2004WO2004035039A1 Heterocyclic amides and their use in treating thromboembolic diseases and tumors
04/29/2004WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives
04/29/2004WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
04/29/2004WO2004004730A3 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders
04/29/2004WO2004000230A3 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
04/29/2004WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
04/29/2004WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
04/29/2004US20040082790 Piperidine amides as modulators of chemokine receptor activity
04/29/2004US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
04/29/2004US20040082785 Process for making an aldehyde
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments